Pulmonary Tuberculosis Without Resistance to Rifampicin

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Pulmonary Tuberculosis Without Resistance to Rifampicin trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT04260477

Novel Triple-dose Tuberculosis Retreatment Regimen

To determine if a high-dose first-line regimen is non-inferior (non-inferiority margin 10%) in terms of safety to the same regimen at regular dosing, in previou…

Niger370 participantsStarted 2021-03-01

Treatment: 6EH³R³Z, 6EHRZ

All recent trials (2 shown)

UnknownPhase 2

NCT01994460

Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis

The current standard short-course treatment for pulmonary TB requires 6 months to complete. This long duration of treatment increases the likelihood of side eff…

South Korea429 participantsStarted 2014-01

Treatment: Linezolid, Ethambutol